48results about How to "Minimize agglomeration" patented technology

A therapeutic device includes a supporting member that continuously and flexibly supports and bounds a plurality of small sized hard surfaced force members that support a user's foot during movement without clumping. The force members are slidable relative to each other and require no additional lubrication although dry or non-tacky liquid lubrication may be added. The support member is positioned on a support surface of a shoe sole and a shoe is constructed including the same. Alternative designs include structural members or positioning stitches relative to the supporting member minimizing undesirable movement of force members during use.

The present invention relates to a metal ink that comprises metal nano particles that are capped by a capping material; and an organic solvent that has a solubility parameter for swelling the capping material. In addition, the present invention relates to a method for producing a metal wire, which comprises the steps of jetting the metal ink by using an ink-jet nozzle, drying the metal ink, and firing the metal ink.

The present invention provides a method of producing particles from solution-in-supercritical fluid or compressed gas emulsions. In accordance with the method of the invention, a solution that includes a solute dissolved in a solvent is contacted with supercritical fluid or compressed gas to form a solution-in-supercritical fluid or compressed gas emulsion. The emulsion is sprayed through an orifice to create spray droplets. The supercritical fluid or compressed gas and the solvent are removed from the spray droplets resulting in the formation of particles that include the solute. In one embodiment of the invention, the solvent is removed from the spray droplets by lyophilization. In another embodiment of the invention, the solvent is removed from the spray droplets by evaporation.

A process for polymerizing monomers in the gas phase, in fluidized bed reactors is described, where unsaturated, gas phase monomers are fed into the reactors in the presence of a mixture of inert diluents having a composition that allows the dew point to be adjusted, this leading to high production rates under stable operation in a non condensed operation mode.

Polymeric particles are provided for use in therapeutic and / or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and / or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.

Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions comprising Ibuprofen using solventless mixing methods. Excess coating material that is not bound to coated Ibuprofen may be removed by a sieving process. Coating and dosing ratios can also be optimized to minimize the amount of excess unbound coating material. Additionally, the compositions can be formulated to preserve the functional coating of coated Ibuprofen and to minimize aeration of Ibuprofen when mixed into suspension.